FDA Inspection 1152638 — LBR Regulatory and Clinical Consulting Services, Inc.
The FDA completed an inspection of LBR Regulatory and Clinical Consulting Services, Inc. on September 14, 2021 in Florence, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 14, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Florence, KY (United States)
Additional Details
Sponsor, Contract Research Organization